New Members Join the Alliance
The CCRA is pleased to announce the addition of two new member organizations: Bladder Cancer Canada and Myeloma Canada, and we welcome new representatives: Michelle Colero, Executive Director, Bladder Cancer Canada and Martine Elias, Executive Director, Myeloma Canada.
Bladder Cancer Canada is the only national patient advocacy organization for the over 80,000 Canadians living with bladder cancer. In addition to its patient support mission, targeted research funding is an important organizational priority.
Myeloma Canada is the only national charitable patient organization created by, and for, Canadians impacted by myeloma. A patient-driven approach to research prioritization guides it research funding decision-making.
We look forward to learning about and from our newest members!
Abstract Submission Now Open!
Abstract submission for the 2023 Canadian Cancer Research Conference is now open. Submissions from the entire spectrum of cancer research topics are welcome. Abstract submission deadline: Friday, June 9, 2023. For more information, go to Read More »
Abstract submission for the 2023 Canadian Cancer Research Conference is now open. Submissions from the entire spectrum of cancer research topics are welcome. Abstract submission deadline: Friday, June 9, 2023. For more information, go to Read More »
Open Call for Research Proposals for BioCanRx
BioCanRx, Canada’s Immunotherapy Network, is launching its first Open Call for Research Proposals, made possible by funding from the Strategic Science Fund. By funding the selected proposals, BioCanRx will increase support for multi-disci... Read More »
BioCanRx, Canada’s Immunotherapy Network, is launching its first Open Call for Research Proposals, made possible by funding from the Strategic Science Fund. By funding the selected proposals, BioCanRx will increase support for multi-disci... Read More »